// App-Quantinova.ai

: A high-performance biomarker panel for Alzheimer’s disease screening and staging identified by large-scale plasma proteomic profiling

Researchers

Presenter

  • Yuanbing JIANG

Principal Investigators

  • Xiaopu Zhou

  • Fanny C. F. Ip

  • Philip Chan

  • Yu Chen

  • Nicole Chit Hang Lai

  • Kit Cheung

  • Ronnie M.N. Lo

  • Estella Pui-Sze Tong

  • Bonnie W.Y. Wong

  • Andrew L.T. Chan

  • Vincent C.T. Mok

  • Timothy CY Kwok

  • Kin Y Mok

  • John A. Hardy

  • Henrik Zetterberg

  • Amy K.Y. Fu

  • Nancy Y. Ip

Medical Centers

  • Division of Life Science, State Key Laboratory of Molecular Neuroscience, Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon

  • Therese Pei Fong Chow Research Centre for Prevention of Dementia, Division of Geriatrics, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin

  • The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences

  • Hong Kong Center for Neurodegenerative Diseases

  • UK Dementia Research Institute, University College London

  • Hong Kong Center for Neurodegenerative Diseases, Hong Kong Science Park

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • Guangdong Provincial Key Laboratory of Brain Science, Disease and Drug Development, HKUST Shenzhen Research Institute, Shenzhen–Hong Kong Institute of Brain Science

  • UK Dementia Research Institute

  • Department of Neurodegenerative Disease, UCL Institute of Neurology

  • Department of Neurodegenerative Disease, UCL Institute of Neurology

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • Divisions of Neurology and Geriatrics, Department of Medicine, Queen Elizabeth Hospital

  • Therese Pei Fong Chow Research Centre for Prevention of Dementia, The Chinese University of Hong Kong

Locations

  • Philippines

  • Hong Kong

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Alzheimer's disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved